Showing results (6851-6860 of 10,083) with videos related to
Sort By:
Pageof 1,009
Current Pharmaceutical Design|April 10, 2013
Will antirheumatic treatment improve cardiovascular outcomes in patients with rheumatoid arthritis?Herwig Pieringer, Max Pichler, Erich Pohanka, et al.Current Pharmaceutical Design|April 10, 2013
Psoriasis and atherosclerosis: Is there a need for novel biomarkers assessing cardiovascular risk?Murat Sunbul, Mehmet AgirbasliCurrent Pharmaceutical Design|April 10, 2013
The biology of the peroxisome proliferator-activated receptor system in the female reproductive tractLeandro Martín Vélez, Giselle Adriana Abruzzese, Alicia Beatriz MottaCurrent Pharmaceutical Design|April 12, 2013
Lipid transmitter signaling as a new target for treatment of cocaine addiction: new roles for acylethanolamides and lysophosphatidic acidLaura Orio, Francisco Javier Pavón, Eduardo Blanco, et al.Current Pharmaceutical Design|April 12, 2013
Neurochemical substrates of MDMA reward: effects of the inhibition of serotonin reuptake on the acquisition and reinstatement of MDMA-induced CPPC Roger-Sánchez, M A Aguilar, C Manzanedo, et al.Current Pharmaceutical Design|May 22, 2013
Novel superactive leptin antagonists and their potential therapeutic applicationsArieh Gertler, Eran ElinavCurrent Pharmaceutical Design|May 22, 2013
Role of C reactive protein (CRP) in leptin resistanceMarta Letizia Hribal, Teresa Vanessa Fiorentino, Giorgio SestiCurrent Pharmaceutical Design|May 22, 2013
Transactivation of ErbB receptors by leptin in the cardiovascular system: mechanisms, consequences and target for therapyJerzy Bełtowski, Anna Jazmroz-WiśniewskaCurrent Pharmaceutical Design|May 22, 2013
Mechanisms linking leptin to arterial and venous thrombosis: potential pharmacological targetsKatrin Schäfer, Stavros KonstantinidesCurrent Pharmaceutical Design|May 22, 2013
Structural basis of resistance to anti-cytochrome bc₁ complex inhibitors: implication for drug improvementLothar Esser, Chang-An Yu, Di XiaPageof 1,009